Australia's most trusted source of pharma news
Wednesday, 23 January 2019
Lost Your Access?
Pharma exec up for Aust of Year
NFP pharma hero nominated for 2019 Australian of the Year.
Monthly scripts anachronistic
Chronic meds should go much longer doc tells colleagues.
Will Keytruda finally be king?
End of Opdivo's reign one of our 2019 PBS predictions.
De Somer wants govt to commit
As the election nears, MA boss calls for clarity on PBS future.
New Roche blood drug arrives
First-in-class scores first priority review tag for 2019.
What next for Novo Nordisk?
Declining PBS income first challenge for incoming MD.
AZ hit by jobs scam
Second pharma targeted by fake recruiters for job seeker cash.
AZ staff make fast exit
Generic competitor may have triggered redundancies.
Novartis reps go virtual
Company bringing in AI assistance
Pharma worker charged
Attempted murder allegation follows multiple stabbings.
'Huge' demand for marcomms staff
Experts sought as pharmas tackle reputation issue.
Aust biotech does CAR-T deal
But Lilly CEO says the new therapies 'not for us'.
Shire dry eye drug arrives
Local win first following Takeda merger.
Push to boost PCSK9s
But docs want compliance with current therapies first.
Export threat under review
Report on Made in Oz havoc due by end February.
Lilly PBAC drug in doubt
Trial setback could damage latest submission.
Claytons election campaign
Leaders hit the hustings with baby-kissing already underway.
New form of Bayer's Xarelto
PBS listing awaits with competition already registered.
Novartis' sickle cell breakthrough
Plus new approvals for Pfizer, BMS.
Events & Conferences
© 2003 - 2019 Lush Media
Pharma in Focus
Jolly Good Design